Earnings and Results
Operating costs fell and the company benefited from a deferred income tax credit.
1
Grab's Singapore e-wallet GrabPay reports higher profit in 2025
2
Vietnam tech giant FPT bets on rising AI demand in Thailand
3
Hong Kong eases listing thresholds to draw more IPOs
4
AI shortens drug discovery to around 1 year in China, Insilico CEO says
5
China to tax offshore trusts as Beijing targets overseas wealth
More Stories
Grab’s Singapore e-wallet GrabPay reports higher profit in 2025
Temasek eyes defence deals as Europe boosts military spending
India: Edelweiss’ EAAA Alternatives returns investor capital from ESOF III
GIC reports lower return on portfolio, identifies AI as key investment focus
Analysis
The company is building partnerships with leading businesses, university.
Policy & Regulations
The steps are part of a wider push by Hong Kong to strengthen its position as a fundraising hub.
Interviews
This gives it an edge over traditional Western pharmaceutical giants.
The rules feature sweeping anti-avoidance provisions.
Greater China
Reuters earlier reported that AgiBot appointed banks in October.
Singapore
Finnomena will offer up to 30,000,838 shares, or 15% of its issued and paid-up shares after the offering.
Besides Singapore’s ST Engineering, Temasek has never really looked at defence.
India
The move follows the exit of a Rs 950-crore investment in a global agrochemicals platform.
Last month, HCLTech acquired a 10.5% stake in Sarvam AI for $150m.
